2016

10732 bookmarks
Newest
Association of habitual glucosamine use with risk of microvascular complications among individuals with type 2 diabetes: a prospective cohort study in UK biobank | Nutrition & Diabetes
Association of habitual glucosamine use with risk of microvascular complications among individuals with type 2 diabetes: a prospective cohort study in UK biobank | Nutrition & Diabetes
Nutrition & Diabetes - Association of habitual glucosamine use with risk of microvascular complications among individuals with type 2 diabetes: a prospective cohort study in UK biobank
·nature.com·
Association of habitual glucosamine use with risk of microvascular complications among individuals with type 2 diabetes: a prospective cohort study in UK biobank | Nutrition & Diabetes
Cellular Fragility Syndrome & C15:0 Deficiency – fatty15
Cellular Fragility Syndrome & C15:0 Deficiency – fatty15
A big paper was just published on a newly discovered nutritional C15:0 deficiency syndrome, called Cellular Fragility Syndrome. This is a big deal because nutritional deficiency syndromes (like vitamin C deficiency and scurvy, or vitamin D deficiency and rickets) are rarely discovered. This latest paper describes how d
·fatty15.com·
Cellular Fragility Syndrome & C15:0 Deficiency – fatty15
Pentadecanoylcarnitine is a newly discovered endocannabinoid with pleiotropic activities relevant to supporting physical and mental health | Scientific Reports
Pentadecanoylcarnitine is a newly discovered endocannabinoid with pleiotropic activities relevant to supporting physical and mental health | Scientific Reports
Scientific Reports - Pentadecanoylcarnitine is a newly discovered endocannabinoid with pleiotropic activities relevant to supporting physical and mental health
·nature.com·
Pentadecanoylcarnitine is a newly discovered endocannabinoid with pleiotropic activities relevant to supporting physical and mental health | Scientific Reports
Dimethyl Sulfoxide (DMSO) - Dr. Stanley Jacob
Dimethyl Sulfoxide (DMSO) - Dr. Stanley Jacob
Dr. Stanley Jacob, the father of DMSO offers information on DMSO & MSM. DMSO (dimethyl sulfoxide), a potent scavenger of free radicals, was first introduced to the scientific community in 1963 by a research team headed by Stanley W. Jacob, MD.
·dmso.org·
Dimethyl Sulfoxide (DMSO) - Dr. Stanley Jacob
DR. SUZANNE HUMPHRIES ON MEASLES MYTHS AND MANIPULATED DATA - The HighWire
DR. SUZANNE HUMPHRIES ON MEASLES MYTHS AND MANIPULATED DATA - The HighWire
Internist and Co-Author of “Dissolving Illusions”, Suzanne Humphries, MD discusses her awakening to the catastrophic dangers of vaccination and walks Del through the data of how severe illness and death from disease declined rapidly across the board years before the introduction of vaccines. Hear how data continues to be manipulated and cherry picked even today […]
·thehighwire.com·
DR. SUZANNE HUMPHRIES ON MEASLES MYTHS AND MANIPULATED DATA - The HighWire
Association between Periodontal Disease and Cognitive Impairment in Adults - PubMed
Association between Periodontal Disease and Cognitive Impairment in Adults - PubMed
All the included studies show evidence of an association between periodontitis and cognitive impairment or dementia and Alzheimer's disease pathology. Nonetheless, the mechanisms responsible for the association between periodontitis and dementia are still unclear and warrant further investigation.
·pubmed.ncbi.nlm.nih.gov·
Association between Periodontal Disease and Cognitive Impairment in Adults - PubMed
Fatty15 Patent Positioning: Our Moral & Legal Responsibilities – fatty15
Fatty15 Patent Positioning: Our Moral & Legal Responsibilities – fatty15
Years ago, while helping to continually improve the health and welfare of aging Navy dolphins, our fatty15 founders discovered C15:0 (aka pentadecanoic acid) as the first essential fatty acid to be identified since omega-3, which was over 90 years ago. For more on our founding story, check out our idea-worth-sharing TE
·fatty15.com·
Fatty15 Patent Positioning: Our Moral & Legal Responsibilities – fatty15
US11116740B2 - Methods for use in support of planned supplement and food ingredient products for diagnosis and treatment of metabolic syndrome - Google Patents
US11116740B2 - Methods for use in support of planned supplement and food ingredient products for diagnosis and treatment of metabolic syndrome - Google Patents
Compositions including an odd chain fatty acid, and salts and derivatives thereof, and methods for metabolic syndrome treatment and prophylaxis are provided, including compositions and methods for treating diabetes, obesity, hyperferritinemia, elevated insulin, glucose intolerance, dyslipidemia and related conditions. Methods for the diagnosis and monitoring of metabolic syndrome are also provided.
·patents.google.com·
US11116740B2 - Methods for use in support of planned supplement and food ingredient products for diagnosis and treatment of metabolic syndrome - Google Patents